IL6 and COVID-19: Several potential mediators of platelet activation exist in COVID-19 patients including cytokines (IL-6, etc.), chemokines and profound endothelial damage, etc. Interestingly, recent evidence has demonstrated expression of ACE2 receptors and TMPRSS2 on platelet surface that can allow direct viral entry in platelets [138].